West Pharmaceutical Services (TICKER: WST) Benchmark And Performance Data

there are 11 of samples in the benchmark for West Pharmaceutical Services in year 2022 in 2022. West Pharmaceutical Services in its benchmark peer group, had rank 9 for gross revenue in 2022. West Pharmaceutical Services in its benchmark peer group, had rank 9 for cost of goods sold as a percent of revenue in 2022. West Pharmaceutical Services in its benchmark peer group, had rank 8 days for days sales outstanding in 2022. West Pharmaceutical Services in its benchmark peer group, had rank 4 for sales growth in 2022. West Pharmaceutical Services in its benchmark peer group, had rank 3 for cash to cash cycle time in 2022. West Pharmaceutical Services in its benchmark peer group, had rank 2 days for days of inventory in 2022. West Pharmaceutical Services headquarters region is East. West Pharmaceutical Services has ticker symbol WST. West Pharmaceutical Services has the following profile: West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.. West Pharmaceutical Services has primary indstury Medical Instruments & Supplies. West Pharmaceutical Services had a $$1,035,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. West Pharmaceutical Services had AptarGroup, and Baxter International, and Dentsply Sirona, and West Pharmaceutical Services, and Intuitive Surgical, and Becton Dickinson, and Envista Holdings, and Hologic, and Cooper Cos., and Teleflex, and ResMed Inc. benchmark peer companies for its SIC code in 2022. West Pharmaceutical Services had 8.83% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. West Pharmaceutical Services had 7 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. West Pharmaceutical Services had 294 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. West Pharmaceutical Services had 14.88% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. West Pharmaceutical Services had 10,700 number of employees in 2022. West Pharmaceutical Services had 0.09% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. West Pharmaceutical Services had 0.00% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. West Pharmaceutical Services had 0 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. West Pharmaceutical Services can reduce overall cost by $$429,000,000 by improving both COGS and SGA to next benchmark tier in 2022. West Pharmaceutical Services can reduce inventory with practices including in 2022. West Pharmaceutical Services can reduce days sales outstanding with practices including in 2022. West Pharmaceutical Services can increase sales revenue by $$1,035,000,000 improving sales performance to next benchmark tier in 2022. West Pharmaceutical Services can increase revenue growth by $$3,000,000 by improving growth performance to next benchmark tier in 2022. West Pharmaceutical Services can increase overall revenue by $$1,038,000,000 by improving both growth and sales performance to next benchmark tier in 2022. West Pharmaceutical Services can increase days payables outstanding with practices including Strategic Sourcing in 2022. West Pharmaceutical Services can increase days payables outstanding by $55,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. West Pharmaceutical Services can improve total financial performance by $$1,578,000,000 by improving revenue, costs, and working capital in 2022. West Pharmaceutical Services can decrease overall working capital by $$111,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. West Pharmaceutical Services can decrease inventory days by $0 days by reducing inventory days to next benchmark tier in 2022. West Pharmaceutical Services can decrease days sales outstanding by $55,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. West Pharmaceutical Services can accelerate revenue growth practices including Revenue-optimized Planning in 2022. West Pharmaceutical Services can accelerate revenue growth practices including Pricing Optimization in 2022. West Pharmaceutical Services can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. The total inventory for West Pharmaceutical Services was $378,400,000.00 in 2021. The total inventory for West Pharmaceutical Services was $321,300,000.00 in 2020. The total inventory for West Pharmaceutical Services was $235,700,000.00 in 2019. The total inventory for West Pharmaceutical Services was $215,200,000.00 in 2017. The total inventory for West Pharmaceutical Services was $214,500,000.00 in 2018. The total inventory for West Pharmaceutical Services was $199,300,000.00 in 2016. The total inventory for West Pharmaceutical Services was $181,500,000.00 in 2014. The total inventory for West Pharmaceutical Services was $181,100,000.00 in 2015. The total inventory for West Pharmaceutical Services was $176,900,000.00 in 2013. The total inventory for West Pharmaceutical Services was $162,200,000.00 in 2012. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $362,800,000.00 in 2021. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $302,000,000.00 in 2020. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $272,700,000.00 in 2019. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $262,900,000.00 in 2018. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $246,000,000.00 in 2017. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $243,900,000.00 in 2015. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $239,600,000.00 in 2016. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $234,900,000.00 in 2013. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $228,700,000.00 in 2014. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $218,100,000.00 in 2012. The sales, general, and administrative (SGA) for West Pharmaceutical Services was $$317,000,000 in 2022. The revenue volatility for West Pharmaceutical Services was 21.45% in 2022. The market capitalization for West Pharmaceutical Services was $34,800,542,000.00 in 2014. The market capitalization for West Pharmaceutical Services was $31,458,414,000.00 in 2013. The market capitalization for West Pharmaceutical Services was $30,433,611,000.00 in 2015. The market capitalization for West Pharmaceutical Services was $28,264,533,000.00 in 2020. The market capitalization for West Pharmaceutical Services was $27,713,465,354.00 in 2021. The market capitalization for West Pharmaceutical Services was $26,573,400,000.00 in 2012. The market capitalization for West Pharmaceutical Services was $25,708,074,000.00 in 2019. The market capitalization for West Pharmaceutical Services was $22,375,380,000.00 in 2016. The market capitalization for West Pharmaceutical Services was $18,209,920,000.00 in 2017. The market capitalization for West Pharmaceutical Services was $17,423,663,490.00 in 2018. The market capitalization for West Pharmaceutical Services was $$25,801,000,000 in 2022. The gross revenue for West Pharmaceutical Services was $2,831,600,000.00 in 2021. The gross revenue for West Pharmaceutical Services was $2,146,900,000.00 in 2020. The gross revenue for West Pharmaceutical Services was $1,839,900,000.00 in 2019. The gross revenue for West Pharmaceutical Services was $1,717,400,000.00 in 2018. The gross revenue for West Pharmaceutical Services was $1,599,100,000.00 in 2017. The gross revenue for West Pharmaceutical Services was $1,509,100,000.00 in 2016. The gross revenue for West Pharmaceutical Services was $1,421,400,000.00 in 2014. The gross revenue for West Pharmaceutical Services was $1,399,800,000.00 in 2015. The gross revenue for West Pharmaceutical Services was $1,368,400,000.00 in 2013. The gross revenue for West Pharmaceutical Services was $1,266,400,000.00 in 2012. The gross revenue for West Pharmaceutical Services was $$2,887,000,000 in 2022. The gross margin for West Pharmaceutical Services was $26.35% in 2022. The days sales outstanding for West Pharmaceutical Services was 63 days in 2022. The days payable outstanding for West Pharmaceutical Services was 47 days in 2022. The days of inventory for West Pharmaceutical Services was $83 in 2022. The cost of goods sold (COGS) for West Pharmaceutical Services was 60.64% in 2022. The cost of goods sold (COGS) for West Pharmaceutical Services was $973,600,000.00 in 2014. The cost of goods sold (COGS) for West Pharmaceutical Services was $944,000,000.00 in 2015. The cost of goods sold (COGS) for West Pharmaceutical Services was $933,700,000.00 in 2013. The cost of goods sold (COGS) for West Pharmaceutical Services was $878,700,000.00 in 2012. The cost of goods sold (COGS) for West Pharmaceutical Services was $1,655,800,000.00 in 2021. The cost of goods sold (COGS) for West Pharmaceutical Services was $1,379,100,000.00 in 2020. The cost of goods sold (COGS) for West Pharmaceutical Services was $1,234,200,000.00 in 2019. The cost of goods sold (COGS) for West Pharmaceutical Services was $1,172,000,000.00 in 2018. The cost of goods sold (COGS) for West Pharmaceutical Services was $1,086,200,000.00 in 2017. The cost of goods sold (COGS) for West Pharmaceutical Services was $1,007,700,000.00 in 2016. The cost of goods sold (COGS) for West Pharmaceutical Services was $$1,751,000,000 in 2022. The cash to cash cycle time for West Pharmaceutical Services was 99 in 2022. The annual percentage growth rate of West Pharmaceutical Services was -0.02% in 2022. 97 days was the measured superior or top ten performance level for cash to cash cycle time in West Pharmaceutical Services's peer group in 2022. 97 days was the measured advantage or top third performance level for days of inventory in West Pharmaceutical Services's peer group in 2022. 83 days was the measured superior or top ten performance level for days of inventory in West Pharmaceutical Services's peer group in 2022. 7.67% was the measured advantage or top third performance level for sales volatility in West Pharmaceutical Services's peer group in 2022. 6.98% was the measured superior or top ten performance level for sales volatility in West Pharmaceutical Services's peer group in 2022. 56 days was the measured parity or middle performance level for days sales outstanding in West Pharmaceutical Services's peer group in 2022. 53 days was the measured advantage or top third performance level for days sales outstanding in West Pharmaceutical Services's peer group in 2022. 52 days was the measured superior or top ten performance level for days sales outstanding in West Pharmaceutical Services's peer group in 2022. 45.77% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in West Pharmaceutical Services's peer group in 2022. 44.22% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in West Pharmaceutical Services's peer group in 2022. 34.38% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in West Pharmaceutical Services's peer group in 2022. 26.35% was the measured superior or top ten performance level for gross margin in West Pharmaceutical Services's peer group in 2022. 125 days was the measured parity or middle performance level for cash to cash cycle time in West Pharmaceutical Services's peer group in 2022. 12.62% was the measured parity or middle performance level for sales volatility in West Pharmaceutical Services's peer group in 2022. 116 days was the measured parity or middle performance level for days of inventory in West Pharmaceutical Services's peer group in 2022. 101 days was the measured advantage or top third performance level for cash to cash cycle time in West Pharmaceutical Services's peer group in 2022. 0.07% was the measured superior or top ten performance level for sales growth in West Pharmaceutical Services's peer group in 2022. -0.03% was the measured parity or middle performance level for sales growth in West Pharmaceutical Services's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in West Pharmaceutical Services's peer group in 2022. $18.89% was the measured advantage or top third performance level for gross margin in West Pharmaceutical Services's peer group in 2022. $14.84% was the measured parity or middle performance level for gross margin in West Pharmaceutical Services's peer group in 2022. $$4,223,000,000 was the measured advantage or top third performance level for gross revenue in West Pharmaceutical Services's peer group. $$3,922,000,000 was the measured parity or middle performance level for gross revenue in West Pharmaceutical Services's peer group in 2022. $$15,113,000,000 was the measured superior or top ten performance level for gross revenue in West Pharmaceutical Services's peer group in 2022.